Application
Western blot analysis of FA57A Antibody (C-term) in mouse NIH-3T3 cell line lysates (35ug/lane). FA57A (arrow) was detected using the purified Pab.Application
FA57A Antibody (C-term) IHC analysis in formalin fixed and paraffin embedded brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the FA57A Antibody (C-term)) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | FA57A Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | FAM57A; Protein FAM57A; Protein CT120 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | FAM57A Protein FAM57A Protein CT120 |
|---|---|
| Molecular Weight(MW) | 29383 Da |
| Tissue Specificity | Highly expressed in pancreas. Detected at intermediate levels in heart, placenta and kidney, and at low levels in brain, liver and skeletal muscle. Not detected in normal lung |
| Cellular Localization | Cell membrane; Multi-pass membrane protein. |
| Entrez Gene | 79850 |
|---|
Application
Western blot analysis of FA57A Antibody (C-term) in mouse NIH-3T3 cell line lysates (35ug/lane). FA57A (arrow) was detected using the purified Pab.
Application
FA57A Antibody (C-term) IHC analysis in formalin fixed and paraffin embedded brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the FA57A Antibody (C-term)) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
